Author(s):
Prashant Nayak, Abhishek Kumar, Raj Kumar Singh, Krishnapriya K R, M Chandana Adiga
Email(s):
abhi12bunty@nitte.edu.in
DOI:
10.52711/0974-360X.2026.00071
Address:
Prashant Nayak1, Abhishek Kumar2*, Raj Kumar Singh¹, Krishnapriya K R2, M Chandana Adiga2
1Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Mangalore, India.
2Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutical Chemistry, Mangalore, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 1,
Year - 2026
ABSTRACT:
Quality assurance in the pharmaceutical industry aims to ensure that the product that reaches the patient is safe, effective, and of better quality. Product quality is checked by various activities of quality systems such as managerial and technical, including evaluation of pharmaceutical products documentation, performing or reviewing quality-control laboratory tests, and monitoring product performance. Managerial activities include selecting reliable suppliers, preparing contract terms, monitoring supplier performance, and performing inspection trials during the distribution network. Compliance Services assures that the labs are operating within global regulatory requirements. By assuring the provider agrees on the protocols under a single Universal Operational Qualification framework, it will have a comprehensive, automated approach to investigation, documentation, and agreement, streamlining processes across all leading pharmaceutical industry models. In pharmaceutical industries, tablet dosage forms should follow the Q10 guidelines of ICH. The models and statistical approaches should qualify as per the guidelines. Observation should be done throughout the life cycle of the tablet dosage form.
Cite this article:
Prashant Nayak, Abhishek Kumar, Raj Kumar Singh, Krishnapriya K R, M Chandana Adiga. A Review on Assurance and Compliance of Manufacturing of Tablets Following ICH Q10. Research Journal of Pharmacy and Technology. 2026;19(1):490-4. doi: 10.52711/0974-360X.2026.00071
Cite(Electronic):
Prashant Nayak, Abhishek Kumar, Raj Kumar Singh, Krishnapriya K R, M Chandana Adiga. A Review on Assurance and Compliance of Manufacturing of Tablets Following ICH Q10. Research Journal of Pharmacy and Technology. 2026;19(1):490-4. doi: 10.52711/0974-360X.2026.00071 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-1-71
REFERENCES:
1. Quality Assurance of Pharmaceuticals. 2nd ed. Geneva: World Health Organization; 2007.
2. Jena S, Arjun G, Kumar DS, Vinod KR et al. Industrial process validation of solid dosage forms-An overview. International Journal of Pharmaceutical Sciences Review and Research. 2010; 4(2): 145-53.
3. Nauman M, Bano R. Implementation of quality risk management (QRM) in pharmaceutical manufacturing industry. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS). 2014; 9(1): 95-101.
4. Reddy VV, Vishal Gupta N, Raghunandan HV, Nitin Kashyap U. Quality risk management in pharmaceutical industry: A review. International Journal of Pharm Tech Research. 2014; 6(3): 908-14.
5. Kumar A, Kumar P, Shravya H, Pai A. Coumarins as potential anticoagulant agents. Research Journal of Pharmacy and Technology. 2022; 15(4): 1659-63. DOI: 10.52711/0974-360X.2022.00277
6. Kumar N, Jha A. Quality risk management during pharmaceutical ‘good distribution practices’–A plausible solution. Bulletin of Faculty of Pharmacy, Cairo University. 2018; 56(1): 18-25. DOI:10.1016/j.bfopcu.2017.12.002
7. Pandey P, Anju G. Quality management system in drug industry: A review. Biomedical Journal of Scientific and Technical Research. 2018; 2(1): 2177-9. DOI: 10.26717/BJSTR.2018.02.000653
8. Bharathy P, Morais SR. Change Control Management: An Overview. Int. J. Life Sci. Pharma Res.2022; 12(1): P79-87. DOI: 10.22376/ijpbs/lpr.2022.12.1.P79-87
9. Wanegaonkar AM, Chaudhari M, Jadhav KR, Kadam VJ. Quality by Design: An Over View in Pharma Industry. Research Journal of Pharmacy and Technology. 2024; 17(7): 3492-8. DOI:10.52711/0974-360X.2024.00546
10. Sharma P. An analytical study of quality management in pharmaceutical industries. International Journal of Management Research and Reviews. 2017; 7(4): 482. DOI:10.14302/issn.2638-4469.japb-17-1534
11. Jain SK, Jain RK. Investigations and CAPA: quality system for continual improvement in pharmaceutical industry. Int J Res Pharm Pharm Sci. 2017; 2: 47-54.
12. Sakkal E, Bitar Y, Trefi S. Quality control of the active Pharmaceutical ingredients of some Pharmaceutical products prior the termination of their shelf life. Research Journal of Pharmacy and Technology. 2019; 12(12): 6111-8. DOI: 10.5958/0974-360X.2019.01062.X
13. Raj A. A review on corrective action and preventive action (CAPA). African Journal of Pharmacy and Pharmacology. 2016; 10(1): 1-6. http://dx.doi.org/10.5897/AJPP2015.4390
14. Wuest T, Irgens C, Thoben KD. An approach to monitoring quality in manufacturing using supervised machine learning on product state data. Journal of Intelligent Manufacturing. 2014; 25: 1167-80. DOI:10.1007/s10845-013-0761-y
15. Das V, Bhairav B, Saudagar RB. Quality by design approaches to analytical method development. Research Journal of Pharmacy and Technology. 2017; 10(9): 3188-94.
16. Aravindan N, Kamaraj R. Change control in pharmaceutical quality management system. Research Journal of Pharmacy and Technology. 2020; 13(4): 1987-90. DOI: 10.5958/0974-360X.2020.00357.1
17. Wanegaonkar AM, Chaudhari M, Jadhav KR, Kadam VJ. Quality by Design: An Over View in Pharma Industry. Research Journal of Pharmacy and Technology. 2024; 17(7): 3492-8. DOI:10.52711/0974-360X.2024.00546
18. Dara SK, Tiwari RN. Pharmaceutical process validation: An industrial perspective. Research Journal of Pharmacy and Technology. 2014; 7(7): 810-4.
19. Shrestha B, Basnett H, Raj PM, Patel SS et al., Process analytical technology: a quality assurance tool. Research Journal of Pharmacy and Technology. 2009; 2(2): 225-7.
20. Kim KW, Lim CH, Joung SH. Analysis of Quality Assurance Items of Film Screen and CR Systems. Research Journal of Pharmacy and Technology. 2017; 10(7): 2106-10. DOI : 10.5958/0974-360X.2017.00368.7
21. Harde M, Lakade S, Wasnik U, Wakade S et al., ICH Guideline in Practice for Quantification of Ruxolitinib by applying Validated RP-HPLC Method on Commercial Tablet Formulation. Research Journal of Pharmacy and Technology. 2024; 17(11): 5242-6.DOI: 10.52711/0974-360X.2024.00802